Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis
Abstract
BACKGROUND: A C-->T substitution at position -589 in the interleukin-4 (IL-4) gene is associated with increased production of IL-4. Associations between this polymorphism and recurrent vulvovaginal candidiasis (RVVC), as well as vaginal concentrations of IL-4 and the anticandidal compounds nitric oxide (NO) and mannose binding lectin (MBL), were evaluated. METHODS: Vaginal samples obtained by lavage from 42 women with RVVC during the acute stage of the disease and 43 control samples were assayed by enzyme-linked immunosorbent assay for IL-4 and NO metabolites. The -589 IL-4 gene polymorphism was detected by polymerase chain reaction and endonuclease digestion. Data were analyzed by Fisher's exact test, the nonparametric Mann-Whitney and Kruskal-Wallis tests, and Spearman rank correlation. P < .05 was considered significant. RESULTS: Candida albicans was identified in 38 patients with RVVC; 3 others had infection due to Candida tropicalis, and 1 had infection due to Candida krusei. The IL-4 T,T genotype was detected in 59.5% of patients with RVVC and in 7.0% of control subjects (P < .0001). The frequency of IL-4*T was 76.2% in patients with RVVC and 23.3% in control subjects (P < .0001). The median concentration of vaginal IL-4 was elevated in patients with RVVC, compared with control subjects (P < .0001). Conversely, vaginal concentrations of NO metabolites (P = .02) and MBL (P < .0001) were reduced in patients with RVVC. There was a positive association between IL-4*T homozygosity and vaginal IL-4 levels (P < .0001) and negative associations between this genotype and vaginal NO (P = .01) and MBL (P < .0001) concentrations. CONCLUSIONS: Reduced vaginal levels of anticandidal factors in IL-4*T homozygotes may increase susceptibility to RVVC.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Polymorphisms in several cytokines are associated with susceptibility to specific fungal diseases: aspergillosis with IL-1, IL-10, IL-15, and IL-23; candidiasis with IL-4; paracoccidioidomycosis with IL-4; and blastomycosis with IL-6.
“polymorphisms in a number of cytokines have also been found to predispose to fungal disease: aspergillosis (IL-1 [30], IL-10 [31,32], IL-15 [32], and IL-23); candidiasis (IL-4) [33,34]; paracoccidioidomycosis (IL-4) [35]; and blastomycosis (IL-6) [36].”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [34]
Cites
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J. D., Xie, Q. W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,184 · see citing works
Backhaus, M., Kamradt, T., SANDROCK, D., Loreck, D., Fritz, J., Wolf, K.-J., Raber, H., Hamm, B., Burmester, G. R., & BOLLOW, M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6 · Cited by 642 · see citing works
Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy
Rosenwasser, L. J., Klemm, D. J., DRESBACK, J., 稲村, 弘., Mascali, J. J., Klinnert, M. D., & Borish, L. (1995) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1995.tb00428.x · Cited by 551 · see citing works
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.
Essner, R., Rhoades, K. L., McBride, W. H., Morton, D., & Economou, J. S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3857 · Cited by 416 · see citing works
Cenci, E., Romani, L. R., Mencacci, A., Spaccapelo, R., Schiaffella, E., Puccetti, P., & Bistoni, F. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230508 · Cited by 244 · see citing works
Babula, O., Lazdāne, G., Kroiča, J., Ledger, W. J., & Witkin, S. S. (2003) · Clinical Infectious Diseases · doi:10.1086/377234 · Cited by 190 · see citing works
Self-citationMicrobiology and Molecular Biology Reviews
(2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/eissn.1098-5557 · Cited by 160 · see citing works
Production and function of cytokines in natural and acquired immunity to Candida albicans infection
Ashman, R. B., & Papadimitriou, J. M. (1995) · Microbiological Reviews · doi:10.1128/mr.59.4.646-672.1995 · Cited by 154 · see citing works
Mårdh, P., Rodrigues, A. G., Genç, M., Novikova, N., Martinez‐de‐Oliveira, J., & Guaschino, S. (2002) · International Journal of STD & AIDS · doi:10.1258/095646202760159639 · Cited by 145 · see citing works
A localized vaginal allergic response in women with recurrent vaginitis
Witkin, S. S., Jeremias, J., & Ledger, W. J. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90909-8 · Cited by 113 · see citing works
Self-citationWitkin, S. S., Hirsch, J., & Ledger, W. J. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(86)80022-9 · Cited by 109 · see citing works
Self-citationGiraldo, P. C. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00577-3 · Cited by 103 · see citing works
Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis
Bendel, C. M. (2003) · Seminars in Perinatology · doi:10.1016/s0146-0005(03)00059-4 · Cited by 96 · see citing works
Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans
Kalo-Klein, A., & Witkin, S. S. (1990) · Infection and Immunity · doi:10.1128/iai.58.1.260-262.1990 · Cited by 93 · see citing works
Self-citationIp, W., & Lau, Y. (2004) · The Journal of Infectious Diseases · doi:10.1086/422397 · Cited by 92 · see citing works
Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis
Fidel, P. L., Lynch, M. E., & Sobel, J. D. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4202-4207.1993 · Cited by 86 · see citing works
History and new insights into host defense against vaginal candidiasis
Fidel, P. L. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.03.006 · Cited by 85 · see citing works
Biological Activities of Naturally Occurring Antibodies Reactive withCandida albicansMannan
Kozel, T. R., MacGill, R. S., Percival, A. L., et al. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.209-218.2004 · Cited by 53 · see citing works
Witkin, S. S., Kalo-Klein, A., Galland, L., et al. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.2.396 · Cited by 29 · see citing works
Self-citationPiccinni, M., Vultaggio, A., Scaletti, C., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/341129 · Cited by 24 · see citing works
Ashman, R. B., Kay, P. H., Lynch, D. M., et al. (1994) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1994.tb125927.x · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793 · see citing works
Sobel, J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60917-9 · Cited by 1,270 · see citing works
Human dectin-1 deficiency and mucocutaneous fungal infections
Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901053 · Cited by 752 · see citing works
Recurrent vulvovaginal candidiasis
Sobel, J. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.067 · Cited by 502 · see citing works
Isolation of vaginal lactobacilli and characterization of anti-candida activity
Parolin, C., Marangoni, A., Laghi, L., Foschi, C., Ñahui Palomino, R. A., Calonghi, N., Cevenini, R., & Vitali, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131220 · Cited by 228 · see citing works
Guideline: Vulvovaginal Candidosis (AWMF 015/072, Level S2k)
Farr, A., Effendy, I., Frey Tirri, B., Hof, H., Mayser, P., Petricevic, L., Ruhnke, M., Schaller, M., Schaefer, A. P. A., Sustr, V., et al. (2021) · Mycoses · doi:10.1111/myc.13248 · Cited by 184 · see citing works
Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (Excluding Chronic Mucocutaneous Candidosis)
Mendling, W. (2015) · Mycoses · doi:10.1111/myc.12292 · Cited by 117 · see citing works
Race and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55 · see citing works
Management of recurrent vulvovaginal candidiasis: Unresolved issues
Sobel, J. D. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0023-7 · Cited by 36 · see citing works
Donders, G. G. G., Mertens, I., Bellen, G., & Pelckmans, S. (2011) · Mycoses · doi:10.1111/j.1439-0507.2009.01754.x · Cited by 28 · see citing works
- Authors
- Babula, O., Lazdane, G., Kroica, J., Linhares, I. M., Ledger, W. J., & Witkin, S. S.
- Affiliations
- Cornell University (US)
- Corresponding author
- Witkin, S. S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-01
- Volume
- 40
- Issue
- 9
- Pages
- 1258-1262
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2133506666
- Cited by
- 130
- References
- 21
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 2 · 2021: 7 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 5 · 2015: 14 · 2014: 11 · 2013: 7 · 2012: 8
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- IL-4, recurrent vulvovaginal candidiasis, nitric oxide, mannose-binding lectin, Candida albicans, genetic susceptibility
- MeSH terms
- Adolescent, Adult, Alleles, Candidiasis, Vulvovaginal, Female, Genotype, Homozygote, Humans, Nitric Oxide, Vagina, Interleukin-4, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Mannose-Binding Lectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review